Employers Back DevelopmentOf Web-Based Health Records
Employers Back Development
Of Web-Based Health Records
Employers Back Development Of Web-Based Health Records - WSJ.com
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
« August 2007 | Main | October 2007 »
Employers Back Development Of Web-Based Health Records - WSJ.com
DACOGEN
About DACOGEN: Treatment for Myelodysplastic Syndromes (MDS)
DACOGEN™ (decitabine) for Injection is a hypomethylating agent indicated to treat patients with myelodysplastic syndromes (MDS), including previously treated and untreated MDS, de novo and secondary MDS of all French-American-British (FAB) subtypes (RA, RARS, RAEB, RAEB-t, CMML*), and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System (IPSS) groups.FDA Approves New Smallpox Vaccine